Tin tức & Cập nhật

Dapagliflozin giúp giảm nguy cơ các biến cố suy tim toàn phần, tử vong do tim mạch ở bệnh nhân suy tim

08 Oct 2023 bởi

Trong một phân tích định trước (prespecified analysis) của nghiên cứu DELIVER*, dapagliflozin – thuộc nhóm SGLT2i giúp giảm tỷ lệ biến cố suy tim toàn phần** hoặc tử vong do tim mạch ở bệnh nhân suy tim có phân suất tống máu bảo tồn hoặc giảm nhẹ (HFmrEF hoặc HFpEF).

Dapagliflozin giúp giảm nguy cơ các biến cố suy tim toàn phần, tử vong do tim mạch ở bệnh nhân suy tim

08 Oct 2023

Fostamatinib safe, effective in moderate-to-severe hidradenitis suppurativa

07 Oct 2023

Treatment with fostamatinib, a spleen tyrosine kinase inhibitor that targets B cells and plasma cells, is well tolerated by patients with hidradenitis suppurativa (HS), resulting in improved clinical outcomes with no serious adverse events, a study has shown.

Fostamatinib safe, effective in moderate-to-severe hidradenitis suppurativa

07 Oct 2023

Canakinumab improves survival in advanced NSCLC

07 Oct 2023 bởi

Treatment with canakinumab appears beneficial to patients with advanced nonsmall cell lung cancer (NSCLC) with low T-cell infiltration (ie, low total count or immune desert phenotype), results of predefined exploratory biomarker analyses from the CANOPY-1 have shown.

Canakinumab improves survival in advanced NSCLC

07 Oct 2023

Sex, ethnicity, comorbidity tied to poor gout control prevalence in SG

06 Oct 2023 bởi

In Singapore, poorly controlled gout appears to be common among men, Malays, and individuals with congestive cardiac failure, as reported in a study.

Sex, ethnicity, comorbidity tied to poor gout control prevalence in SG

06 Oct 2023

Is it safe to administer lacosamide and levetiracetam via IV push?

06 Oct 2023

Use of undiluted lacosamide and levetiracetam to prevent seizures does not result in significant adverse events when administered via intravenous (IV) push over 5 min, according to a study. This approach appears to be a safe alternative form of administration to intermittent infusion.

Is it safe to administer lacosamide and levetiracetam via IV push?

06 Oct 2023

Liraglutide vs semaglutide: Which is a better GLP-1 RA for diabetic veterans?

06 Oct 2023

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) liraglutide and semaglutide are both effective at lowering haemoglobin A1c (A1c) among veterans with type 2 diabetes mellitus (T2DM), reports a recent study, which provides insights into key considerations for this population.

Liraglutide vs semaglutide: Which is a better GLP-1 RA for diabetic veterans?

06 Oct 2023

Thuốc tránh thai đường uống không làm tăng nguy cơ bệnh tim mạch và tử vong do mọi nguyên nhân

06 Oct 2023

Một nghiên cứu cho thấy, thuốc tránh thai đường uống không làm tăng nguy cơ mắc các biến cố liên quan đến bệnh tim mạch và tử vong do mọi nguyên nhân ở phụ nữ, những người sử dụng biện pháp tránh thai này lâu dài còn có khả năng nhận được lợi ích trên tim mạch.

Thuốc tránh thai đường uống không làm tăng nguy cơ bệnh tim mạch và tử vong do mọi nguyên nhân

06 Oct 2023

$Early-life exposure to acid suppressants may up risk of fractures during childhood$

Early-life exposure to acid suppressants may up risk of fractures during childhood

06 Oct 2023

Exposure to acid-suppressive therapy during the first year of life appear to come with a small but significant increase in the risk of fractures, according to a study.

Early-life exposure to acid suppressants may up risk of fractures during childhood

06 Oct 2023

“Forever chemicals” a culprit in delayed puberty in girls

05 Oct 2023 bởi

Exposure to per- and polyfluoroalkyl substances (PFAS), dubbed “forever chemicals,” may contribute to a delay in puberty through its effects on body mass index (BMI) and sex hormones, as shown in a study.

“Forever chemicals” a culprit in delayed puberty in girls

05 Oct 2023

Muvalaplin for lowering Lp(a) succeeds in early-phase trial

05 Oct 2023

The selective small molecule inhibitor of lipoprotein(a) (Lp[a]) formation muvalaplin helps reduce Lp(a) levels by up to 65 percent without safety and tolerability signals, as shown in the results of a phase I trial.

Muvalaplin for lowering Lp(a) succeeds in early-phase trial

05 Oct 2023

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Dapagliflozin giúp giảm nguy cơ các biến cố suy tim toàn phần, tử vong do tim mạch ở bệnh nhân suy tim

Dapagliflozin giúp giảm nguy cơ các biến cố suy tim toàn phần, tử vong do tim mạch ở bệnh nhân suy tim

Fostamatinib safe, effective in moderate-to-severe hidradenitis suppurativa

Fostamatinib safe, effective in moderate-to-severe hidradenitis suppurativa

Canakinumab improves survival in advanced NSCLC

Canakinumab improves survival in advanced NSCLC

Sex, ethnicity, comorbidity tied to poor gout control prevalence in SG

Sex, ethnicity, comorbidity tied to poor gout control prevalence in SG

Is it safe to administer lacosamide and levetiracetam via IV push?

Is it safe to administer lacosamide and levetiracetam via IV push?

Liraglutide vs semaglutide: Which is a better GLP-1 RA for diabetic veterans?

Liraglutide vs semaglutide: Which is a better GLP-1 RA for diabetic veterans?

Thuốc tránh thai đường uống không làm tăng nguy cơ bệnh tim mạch và tử vong do mọi nguyên nhân

Thuốc tránh thai đường uống không làm tăng nguy cơ bệnh tim mạch và tử vong do mọi nguyên nhân

Early-life exposure to acid suppressants may up risk of fractures during childhood

Early-life exposure to acid suppressants may up risk of fractures during childhood

“Forever chemicals” a culprit in delayed puberty in girls

“Forever chemicals” a culprit in delayed puberty in girls

Muvalaplin for lowering Lp(a) succeeds in early-phase trial

Muvalaplin for lowering Lp(a) succeeds in early-phase trial